Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Predicting Drug Sensitivity in Cancer Cell Lines Using Contextualized Prior Knowledge Networks and Graph Neural Networks
Download
Deniz Germen - Predicting Drug Sensitivity in Cancer Cell Lines Using Contextualized Prior Knowledge Networks and Graph Neural Networks.pdf
Date
2025-1-10
Author
Germen, Deniz
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
41
views
0
downloads
Cite This
The discovery and development of effective anticancer therapies face high failure rates, often due to inadequate target efficacy, unintended off-target toxicity, and molecular heterogeneity among tumors. To address these challenges and enhance precision oncology, we introduces an integrated computational framework that combines multi-omics data, prior knowledge networks, and deep learning architectures for predicting drug sensitivity in cancer cell lines. A central contribution of this work is the explicit integration of these prior knowledge networks, which allows us to incorporate established biological interactions and thereby improve both the interpretability and robustness of our models. We leverage transcriptomic data to infer transcription factor activities using univariate linear models and incorporate curated biological networks to capture regulatory interactions. These representations are refined using MOON (Meta-fOOtprint aNalysis), ensuring context-specific, biologically consistent network embeddings. On the compound side, we represent drugs using Extended Connectivity Fingerprints (ECFPs), capturing essential structural features in a machine-readable format. A Graph Neural Network (GNN) is employed to learn from these contextually enriched prior knowledge networks, while a feed-forward neural network processes the ECFP vectors. By merging these learned representations, we predict half-maximal inhibitory concentrations (IC50) for various cell line–drug combinations. We benchmark our approach against classical regression and machine learning models, comparing the predictive performance of raw gene expression, transcription factor activities, and MOON-refined representations.
Subject Keywords
Drug sensitivity prediction
,
Graph neural networks
,
Prior knowledge networks
,
Omics data integration
,
Deep learning
URI
https://hdl.handle.net/11511/113522
Collections
Graduate School of Natural and Applied Sciences, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. Germen, “Predicting Drug Sensitivity in Cancer Cell Lines Using Contextualized Prior Knowledge Networks and Graph Neural Networks,” M.S. - Master of Science, Middle East Technical University, 2025.